Duns Number:092815364
Device Description: TRU RSV is a rapid, qualitative, lateral-flow immunoassay for the detection of Respiratory TRU RSV is a rapid, qualitative, lateral-flow immunoassay for the detection of Respiratory Syncytial Virus (RSV) antigens (fusion protein or nucleoprotein) in human nasal wash, nasopharyngeal aspirate, and nasal and nasopharyngeal swab samples. It is designed to be used by clinical laboratories to test specimens from symptomatic patients aged five years or less. A negative result does not preclude RSV infection. It is recommended that all negative test results be confirmed by cell culture. The results of this test are used in combination with other clinical tests and the patients’ conditions to diagnose RSV-associated infections.
Catalog Number
751330
Brand Name
TRU RSV
Version/Model Number
751330
Device Commercial Distribution Status
In Commercial Distribution
Commercial Distribution End Date
-
Issuing Agency
In GS1
MRI safety Status
Labeling does not contain MRI Safety Information
Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)
-
Device labeled as "Not made with natural rubber latex"
-
For Single-Use
Yes
Prescription Use (Rx)
Yes
Over the Counter (OTC)
-
Kit
-
Combination Product
-
Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)
-
FDA Premarket Submission
K071101
Product Code
GQG
Product Code Name
Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus
Public Device Record Key
fa06a8be-f716-4805-b6bf-802631dc43a2
Public Version Date
June 10, 2022
Public Version Number
2
DI Record Publish Date
December 09, 2020
Package DI Number
None
Quantity per Package
-
Contains DI Package
-
Package Discontinue Date
-
Package Status
-
Package Type
-
Device Class | Device Class Description | No of Devices |
---|---|---|
1 | A medical device with low to moderate risk that requires general controls | 149 |
2 | A medical device with a moderate to high risk that requires special controls. | 46 |
3 | A medical device with high risk that requires premarket approval | 1 |